| 1. |
- Acquavella, J., et al.
(författare)
-
Design and methods for a Scandinavian pharmacovigilance study of osteonecrosis of the jaw and serious infections among cancer patients treated with antiresorptive agents for the prevention of skeletal-related events
- 2016
-
Ingår i: Clinical Epidemiology. - 1179-1349. ; 8, s. 267-272
-
Tidskriftsartikel (refereegranskat)abstract
- Objective: Osteonecrosis of the jaw (ONJ) is a recognized complication of potent antiresorptive therapies, especially at the doses indicated to prevent skeletal complications for cancer patients with bone metastases. This paper describes the rationale and methods for a prospective, post-authorization safety study of cancer patients treated with antiresorptive therapies. Methods: As part of a comprehensive pharmacovigilance plan, developed with regulators' input, the study will estimate incidence of ONJ and of serious infections among adult cancer patients with bone metastases treated with denosumab (120 mg subcutaneously) or zoledronic acid (4 mg intravenously, adjusted for renal function). Patients will be identified using routinely collected data combined with medical chart review in Denmark, Sweden, and Norway. Followup will extend from the first administration of antiresorptive treatment to the earliest of death, loss-to-follow-up, or 5 years after therapy initiation. Results will be reported for three treatment cohorts: denosumab-naive patients, zoledronic acid-naive patients, and patients who switch from bisphosphonate treatment to denosumab. ONJ cases will be identified in three newly established national ONJ databases and adjudicated by the committee that functioned during the XGEVA (R) clinical trials program. Conclusion: This study will provide a real world counterpart to the clinical trial-estimated risks for ONJ and serious infections for cancer patients initiating denosumab or zoledronic acid. The establishment of ONJ databases in the three Scandinavian countries will have potential benefits outside this study for the elucidation of ONJ risk factors and the evaluation of ONJ treatment strategies.
|
|
| 2. |
|
|
| 3. |
- Gupta, Mohit Kumar, 1986-, et al.
(författare)
-
Influence of bondcoat surface characteristics on lifetime in suspension plasma sprayed thermal barrier coatings
- 2017
-
Ingår i: Proceedings of the International Thermal Spray Conference & Exposition (ITSC 2017). - New York : Curran Associates, Inc. - 9781510858220 ; , s. 883-887
-
Konferensbidrag (refereegranskat)abstract
- Development of TBCs allowing higher combustion temperatures in gas turbines is of high commercial interest since it results in higher fuel efficiency and lower emissions. It is well known that TBCs produced by suspension plasma spraying (SPS) have lower thermal conductivity as compared to conventional systems due to their very fine porous microstructure. Moreover, columnar structured SPS TBCs are significantly cheaper to produce as compared to the conventionally used electron beam - physical vapour deposition (EB-PVD). However, SPS TBCs have not yet been commercialised due to low reliability and life expectancy of the coatings. Lifetime of a TBC system is significantly dependent on topcoat-bondcoat interface topography. The objective of this work was to study the effect of topcoat-bondcoat interface in SPS TBCs by changing bondcoat spray parameters and bondcoat surface heat treatment High velocity air fuel (HVAF) spraying was used for bondcoat deposition while axial-SPS was used for topcoat deposition. Same topcoat spray parameters were used for all samples. Lifetime was examined by thermal cyclic fatigue and thermal shock testing. The influence of surface roughness on lifetime has been discussed. The results show that HVAF could be a suitable process for bondcoat deposition to achieve long lifetime SPS TBCs.
|
|
| 4. |
- Hovland, A, et al.
(författare)
-
Om ångestsyndrom
- 2018
-
Ingår i: Fysisk aktivitet som medicin. - Stockholm : SISU idrottsböcker. - 9789177270355 ; , s. 293-298
-
Bokkapitel (populärvet., debatt m.m.)
|
|
| 5. |
- Martinsen, E, et al.
(författare)
-
Om depression
- 2018
-
Ingår i: Fysisk aktivitet som medicin. - Stockholm : SISU idrottsböcker. - 9789177270355 ; , s. 177-182
-
Bokkapitel (populärvet., debatt m.m.)
|
|
